Skip to content

ELECTRA THERAPEUTICS INC

US · ETRA #3672 by market cap Listed 2026
8.11 -0.83 -9.28%
Periodic snapshot; not a real-time feed. · 2026-11-20 16:15

Price chart

Pre-market 8.70 -2.68%
After-hours 8.11 0.00%
13.927.318.112026-09-182026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on ETRA?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Main-fund capital flow has been a net outflow over the last 41 sessions.
  • Short interest has fallen to 0.8% of float.
  • Analyst tilt is Buy.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Key statistics

Price & volume

Prev close
8.94
Open
8.85
Day range
8.07 - 9.65
Avg price
8.45
Volume
376.12K
Turnover
3.18M
Amplitude
17.67%
52-week range
6.87 - 15.50

Valuation

P/E
-8.00
P/E (TTM)
-5.05
P/B
1.30
EPS
-1.01
Net profit
-63.75M
Net assets
392.92M

Share structure

Market cap
509.85M
Float cap
258.42M
Shares out
62.87M
Float shares
31.86M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2026-09-18
52-week range 14% of range
6.87 15.50

47.7% below the 52-week high

Trading activity

Net capital flow main funds, last 41 sessions

-6.13M net over the window

Short interest

Shares short
484.02K
As of
2026-10-30

Frequently asked questions

What is the current stock price of ELECTRA THERAPEUTICS INC (ETRA)?

ELECTRA THERAPEUTICS INC last traded at 8.11. This page shows a periodic quote snapshot. Check the displayed quote time.

What is ELECTRA THERAPEUTICS INC's market cap?

About 509.85M.

What is the P/E ratio of ELECTRA THERAPEUTICS INC?

The trailing twelve-month P/E is -5.05. The Valuation tab shows it against the stock's own five-year range.

Does ELECTRA THERAPEUTICS INC pay a dividend?

ELECTRA THERAPEUTICS INC does not currently pay a regular dividend.

Is ELECTRA THERAPEUTICS INC a buy according to analysts?

The consensus of 5 analysts is a Buy rating, with an average 12-month price target of 32.67, which implies 302.8% upside from the current price. This is not investment advice.

What is ELECTRA THERAPEUTICS INC's StockVane Quant Rating?

The StockVane Momentum strategy currently rates ELECTRA THERAPEUTICS INC a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 16:15:00 · For reference only, not investment advice and not tailored to your situation.

ELECTRA THERAPEUTICS INC discussion 0 comments

Add a comment